Global Microbial Gene Editing Services Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Tools;

Meganucleases (MNs), , Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), CRISPR/Cas9, Targetrons, Peptide Nucleic Acids (PNAs), Triplex-Forming Oligonucleotides (TFOs), and Structure-Guided Endonucleases.

By Application;

Industrial Applications, Pharmaceutical applications, Environmental applications, and Agricultural applications.

By End User;

Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn123563953 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Microbial Gene Editing Services Market (USD Million), 2021 - 2031

In the year 2024, the Global Microbial Gene Editing Services Market was valued at USD 7,434.48 million. The size of this market is expected to increase to USD 24,567.23 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.6%.

Microbial gene editing services entail the manipulation of genetic material within microorganisms such as bacteria, yeast, and algae to achieve specific outcomes, ranging from enhancing industrial processes to developing novel therapeutics. This market is witnessing remarkable growth driven by a confluence of factors, including advancements in gene editing technologies such as CRISPR-Cas9, increasing demand for customized microbial strains for industrial applications, and growing investments in synthetic biology research. The expanding scope of microbial gene editing beyond traditional fields like biopharmaceuticals and biofuel production into areas such as agriculture, environmental remediation, and food production is broadening the market's horizons and stimulating innovation.

The pharmaceutical and biotechnology sectors are major contributors to the growth of the microbial gene editing services market, leveraging these services to accelerate drug discovery and development processes, particularly in the production of biologics and vaccines. The adoption of microbial gene editing in industrial biotechnology is revolutionizing manufacturing processes by enabling the production of bio-based chemicals, enzymes, and other products with enhanced properties and sustainability profiles. In agriculture, microbial gene editing holds promise for addressing global food security challenges by developing crop varieties with improved yield, disease resistance, and nutritional content. The increasing awareness of the environmental impact of traditional industrial practices is driving the adoption of microbial gene editing for eco-friendly solutions such as bio-remediation and waste management.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Tools
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Microbial Gene Editing Services Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. CRISPR advances fueling efficiency
        2. Growing demand for tailored microbial strains
        3. Need for enhanced traits in agriculture, biofuel
        4. Expanding gene therapy applications
      2. Restraints
        1. Ethical concerns on genetic manipulation
        2. Ecological uncertainty post gene editing
        3. Regulatory compliance challenges
      3. Opportunities
        1. Entry into emerging biotech markets
        2. Collaboration with academia for research
        3. Partnerships to navigate regulations
        4. Innovation in precise microbial modifications
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Microbial Gene Editing Services Market, By Tools, 2021 - 2031 (USD Million)
      1. Meganucleases (MNs)
      2. Zinc Finger Nucleases (ZFNs)
      3. Transcription Activator-Like Effector Nucleases (TALENs)
      4. CRISPR/Cas9
      5. Targetrons
      6. Peptide Nucleic Acids (PNAs)
      7. Triplex-Forming Oligonucleotides (TFOs)
      8. Structure-Guided Endonucleases
    2. Global Microbial Gene Editing Services Market, By Application, 2021 - 2031 (USD Million)
      1. Industrial Applications
      2. Pharmaceutical Applications
      3. Environmental Applications
      4. Agricultural Applications
    3. Global Microbial Gene Editing Services Market, By End User, 2021 - 2031 (USD Million)
      1. Biotechnological Companies
      2. Pharmaceutical Companies
      3. Contract Research Organizations
      4. Academic Research Institutes
    4. Global Microbial Gene Editing Services Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Creative Biogene
      2. GeneCopoeia, Inc
      3. ProteoGenix
      4. Thermo Fisher Scientific Inc.
      5. Vigene Biosciences Inc.
      6. Biotools Co., Ltd
      7. Cellecta, In
      8. NemaMetrix Inc.
      9. GenScript Biotech Corp
      10. OriGene Technologies, Inc
      11. Synbio Technologies LLC
      12. Rockland Immunochemicals Inc
  7. Analyst Views
  8. Future Outlook of the Market